Key result
Impella 2.5 successfully managed a case of cardiogenic shock due to Takotsubo cardiomyopathy complicated by left ventricular outflow tract obstruction.
Why the study?
Cardiogenic shock due to Takotsubo cardiomyopathy is often managed with fluids and inotropes, but co-existing LVOTO can complicate this approach.
Case Report (n=1)
Impella 2.5 may be a viable mechanical circulatory support option for managing cardiogenic shock in Takotsubo cardiomyopathy complicated by left ventricular outflow tract obstruction.
May support Impella consideration in refractory Takotsubo shock with LVOTO; single case leaves open need for prospective data.
Cardiogenic shock (CS) due to Takotsubo cardiomyopathy (TCM) is often managed with cautious fluid administration and inotropic support; however, the co-existence of a left ventricular outflow tract obstruction (LVOTO) can complicate this management approach. This report describes a case of CS due to TCM and LVOTO. It was successfully managed with the Impella 2.5. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Mohammedzein et al. (2019) conducted a case report in Cardiogenic shock due to Takotsubo cardiomyopathy with left ventricular outflow tract obstruction (n=1). Impella 2.5 was evaluated on Successful management. Impella 2.5 successfully managed a case of cardiogenic shock due to Takotsubo cardiomyopathy complicated by left ventricular outflow tract obstruction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: